StonvexLoading…
StonvexStonvexStonvexCore line items from GO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.69B | $4.37B | $3.97B | $3.58B |
Operating Income | $-221.71M | $78.33M | $125.78M | $94.99M |
Net Income | $-224.91M | $39.47M | $79.44M | $65.05M |
EPS (Diluted) | $-2.30 | $0.40 | $0.79 | $0.65 |
Total Assets | $3.09B | $3.17B | $2.97B | $2.77B |
Total Liabilities | $2.11B | $1.98B | $1.75B | $1.66B |
Cash & Equivalents | $69.60M | $62.83M | $114.99M | $102.73M |
Free Cash Flow OCF − CapEx | $23.80M | $-74.65M | $134.46M | $55.03M |
Shares Outstanding | 98.15M | 97.26M | 99.22M | 97.67M |